1. The role of osteopontin in the development and metastasis of melanoma
   Yun Zhao et al, 2021, Melanoma Research CrossRef
2. Prospective Validation of Molecular Prognostic Markers in Cutaneous Melanoma: A Correlative Analysis of E1690
   Mohammed Kashani-Sabet et al, 2017, Clinical Cancer Research CrossRef
3. Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT
   Peter J Selby et al, 2018, Programme Grants for Applied Research CrossRef
4. Angiogenesis, vasculogenic mimicry and vascular invasion in cutaneous malignant melanoma – implications for therapeutic strategies and targeted therapies
   Hye Jin Chung et al, 2014, Expert Review of Anticancer Therapy CrossRef
5. The role of osteopontin expression in melanoma progression
   Timea Kiss et al, 2015, Tumor Biology CrossRef
6. Increased Circulating Osteopontin Levels Promote Primary Tumour Growth, but Do Not Induce Metastasis in Melanoma
   Rafael Saup et al, 2023, Biomedicines CrossRef
7. Unraveling the Wide Spectrum of Melanoma Biomarkers
   Antonios Revythis et al, 2021, Diagnostics CrossRef
8. Osteopontin at the Crossroads of Inflammation and Tumor Progression
   Luigi Mario Castello et al, 2017, Mediators of Inflammation CrossRef
9. Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial
   Lina Prasmickaite et al, 2015, Cancer Immunology, Immunotherapy CrossRef
10. Role of osteopontin in the pathophysiology of cancer
    Lalita A. Shevde et al, 2014, Matrix Biology CrossRef
11. Combining Biomarkers for the Diagnosis of Metastatic Melanoma
    Tünde Várvölgyi et al, 2023, Journal of Clinical Medicine CrossRef
12. Plasma osteopontin in acute liver failure
    Praveen Srungaram et al, 2015, Cytokine CrossRef